Childhood cancer survivorship research in minority populations: A position paper from the childhood cancer survivor study

Cancer

Volumn 122, Issue 15, 2016, Pages

  Bhatia, Smita ^a   Gibson, Todd M ^b   Ness, Kirsten K ^b   Liu, Qi ^c   Oeffinger, Kevin C ^d   Krull, Kevin R ^b   Nathan, Paul C ^g   Neglia, Joseph P ^e   Leisenring, Wendy ^f   Yasui, Yutaka ^b,c   Robison, Leslie L ^b   Armstrong, Gregory T ^b  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f Fred Hutchinson Cancer Research Center   (United States)

^g HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVAL; CARDIOMYOPATHY; CHILDHOOD CANCER; CHILDHOOD CANCER SURVIVOR; COMORBIDITY; EDUCATIONAL STATUS; ETHNIC DIFFERENCE; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HIGH RISK BEHAVIOR; HUMAN; HYPERTENSION; INCOME; MINORITY GROUP; PATIENT PARTICIPATION; PRIORITY JOURNAL; RACE DIFFERENCE; RADIATION INDUCED NEOPLASM; RISK FACTOR; SOCIAL STATUS; UNITED STATES; ADOLESCENT; AGE; CHILD; ETHNOLOGY; HEALTH BEHAVIOR; HEALTH SURVEY; INCIDENCE; INFANT; MORTALITY; NEOPLASMS; NEWBORN; PATIENT ATTITUDE; PRESCHOOL CHILD; STATISTICS AND NUMERICAL DATA; SURVIVOR;

ADOLESCENT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; COMORBIDITY; HEALTH BEHAVIOR; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MINORITY GROUPS; MORTALITY; NEOPLASMS; PATIENT ACCEPTANCE OF HEALTH CARE; POPULATION SURVEILLANCE; RISK-TAKING; SURVIVORS; UNITED STATES;

EID: 84995584851     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.30072     Document Type: Article

References (86)

1. Colby SL. Projections of the size and composition of the U.S. Population: 2014 to 2060: United States Census Bureau 2015.
2. Perez AD, Hirschman C. The Changing Racial and Ethnic Composition of the US Population: Emerging American Identities. Popul Dev Rev 2009;35:1-51.
3. Hobbs F, Stoops N. Demographic Trends in the 20th Century. Census 2000 Special Reports USCB, Series CENSR-4 Washington, D.C.: U.S. Government Printing Office; 2002.
4. Census Briefs, Overview of Race and Hispanic Origin 2010. at www.census.gov/library/publications/2011/dec/c2010br-02.html.
5. Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin 2014;64:83-103.
6. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006;355:1572-82.
7. Mertens AC, Liu Q, Neglia JP, et al. Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst 2008;100:1368-79.
8. Hudson MM, Ness KK, Gurney JG, et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA 2013;309:2371-81.
9. Inskip PD, Robison LL, Stovall M, et al. Radiation dose and breast cancer risk in the childhood cancer survivor study. J Clin Oncol 2009;27:3901-7.
10. Neglia JP, Robison LL, Stovall M, et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 2006;98:1528-37.
11. Bhatia S. Disparities in cancer outcomes: lessons learned from children with cancer. Pediatr Blood Cancer 2011;56:994-1002.
12. Surveillance, Epidemiology, and End Results Program. at http://seer.cancer.gov/registries/terms.html
13. Robison LL, Armstrong GT, Boice JD, et al. The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research. J Clin Oncol 2009;27:2308-18.
14. National Cancer Institute SEER*Stat software. at seer.cancer.gov/seerstat
15. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000;19:335-51.
16. Joinpoint Regression Program, Version 4.2.0.: National Cancer Institute; 2015.
17. Baade PD, Youlden DR, Valery PC, et al. Trends in incidence of childhood cancer in Australia, 1983-2006. Br J Cancer 2010;102:620-6.
18. Stiller CA, Marcos-Gragera R, Ardanaz E, et al. Geographical patterns of childhood cancer incidence in Europe, 1988-1997. Report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006;42:1952-60.
19. Kaatsch P, Steliarova-Foucher E, Crocetti E, Magnani C, Spix C, Zambon P. Time trends of cancer incidence in European children (1978-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006;42:1961-71.
20. Steliarova-Foucher E, Stiller C, Kaatsch P, et al. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCISproject): an epidemiological study. Lancet 2004;364:2097-105.
21. Linabery AM, Ross JA. Childhood and adolescent cancer survival in the US by race and ethnicity for the diagnostic period 1975-1999. Cancer 2008;113:2575-96.
22. Armstrong GT, Chen Y, Yasui Y, et al. Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer. N Engl J Med 2016.
23. Bhatti P, Veiga LH, Ronckers CM, et al. Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study. Radiat Res 2010;174:741-52.
24. Phillips SM, Padgett LS, Leisenring WM, et al. Survivors of childhood cancer in the United States: prevalence and burden of morbidity. Cancer Epidemiol Biomarkers Prev 2015;24:653-63.
25. Liu Q, Leisenring W, Ness KK, et al. Racial/ ethnic differences in adverse outcomes among childhood cancer survivors: The Childhood Cancer Survivor Study. J Clin Oncol 2016, in press.
26. Oeffinger KC, Mertens AC, Hudson MM, et al. Health care of young adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Fam Med 2004;2:61-70.
27. In: Hewitt M, Weiner SL, Simone JV, eds. Childhood Cancer Survivorship: Improving Care and Quality of Life. Washington (DC)2003.
28. Children’s Oncology Group. Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers. Version 4.0. 2014. at http://www.survivorshipguidelines.org
29. Statistics. With Chartbook on trends in the Health of Americans. 2006.
30. Bureau USC. Current Population Survey. Annual Social and Economic Supplement. 2003.
31. Prevention CfDCa. The health consequences of smoking: A report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2004.
32. Substance Abuse and Mental Health Services Administration, Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-41. Rockville, MD: HHS Publication No. (SMA) 11-4658; 2011.
33. Corbie-Smith G, Flagg EW, Doyle JP, O'Brien MA. Influence of usual source of care on differences by race/ethnicity in receipt of preventive services. J Gen Intern Med 2002;17:458-64.
34. Johnson JA. Ethnic differences in cardiovascular drug response: potential contribution of pharmacogenetics. Circulation 2008;118:1383-93.
35. Best T, Li D, Skol AD, et al. Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma. Nat Med 2011;17:941-3.
36. Bhatia S. Genetic variation as a modifier of association between therapeutic exposure and subsequent malignant neoplasms in cancer survivors. Cancer 2015;121:648-63.
37. Blanco JG, Sun CL, Landier W, et al. Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group. J Clin Oncol 2012;30:1415-21.
38. Wang X, Liu W, Sun CL, et al. Hyaluronan synthase 3 variant and anthracycline-related cardiomyopathy: a report from the children's oncology group. J Clin Oncol 2014;32:647-53.
39. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2011. Bethesda, MD: National Cancer Institute; 2014.
40. Klein DJ, Elliott MN, Haviland AM, et al. Understanding nonresponse to the 2007 Medicare CAHPS survey. Gerontologist 2011;51:843-55.
41. Ofstedal MB, Weir DR. Recruitment and retention of minority participants in the health and retirement study. Gerontologist 2011;51 Suppl 1:S8-20.
42. Sykes LL, Walker RL, Ngwakongnwi E, Quan H. A systematic literature review on response rates across racial and ethnic populations. Can J Public Health 2010;101:213-9.
43. Wendler D, Kington R, Madans J, et al. Are racial and ethnic minorities less willing to participate in health research? PLoS Med 2006;3:e19.
44. Steffen AD, Kolonel LN, Nomura AM, Nagamine FS, Monroe KR, Wilkens LR. The effect of multiple mailings on recruitment: the Multiethnic Cohort. Cancer Epidemiol Biomarkers Prev 2008;17:447-54.
45. Butler TL, Fraser GE, Beeson WL, et al. Cohort profile: The Adventist Health Study-2 (AHS-2). Int J Epidemiol 2008;37:260-5.
46. Herring RP, Butler T, Hall S, Montgomery SB, Fraser GE. Recruiting black Americans in a large cohort study: the Adventist Health Study-2 (AHS-2) design, methods and participant characteristics. Ethn Dis 2010;20:437-43.
47. Howard BV, Devereux RB, Cole SA, et al. A genetic and epidemiologic study of cardiovascular disease in Alaska natives (GOCADAN): design and methods. Int J Circumpolar Health 2005;64:206-21.
48. Annuzzi G, Rivellese AA, Wang H, et al. Lipoprotein subfractions and dietary intake of n-3 fatty acid: the Genetics of Coronary Artery Disease in Alaska Natives study. Am J Clin Nutr 2012;95:1315-22.
49. Fuqua SR, Wyatt SB, Andrew ME, et al. Recruiting African-American research participation in the Jackson Heart Study: methods, response rates, and sample description. Ethn Dis 2005;15:S6-18-29.
50. Forthofer RN. Investigation of nonresponse bias in NHANES II. Am J Epidemiol 1983;117:507-15.
51. Woteki CE, Briefel R, Hitchcock D, Ezzati T, Maurer K. Selection of nutrition status indicators for field surveys: the NHANES III design. J Nutr 1990;120 Suppl 11:1440-5.
52. Lee ET, Welty TK, Fabsitz R, et al. The Strong Heart Study. A study of cardiovascular disease in American Indians: design and methods. Am J Epidemiol 1990;132:1141-55.
53. Milam JE, Meeske K, Slaughter RI, et al. Cancer-related follow-up care among Hispanic and non-Hispanic childhood cancer survivors: The Project Forward study. Cancer 2015;121:605-13.
54. Harlan LC, Lynch CF, Keegan TH, et al. Recruitment and follow-up of adolescent and young adult cancer survivors: the AYA HOPE Study. J Cancer Surviv 2011;5:305-14.
55. Arora NK, Hamilton AS, Potosky AL, et al. Population-based survivorship research using cancer registries: a study of non-Hodgkin's lymphoma survivors. J Cancer Surviv 2007;1:49-63.
56. McTiernan A, Rajan KB, Tworoger SS, et al. Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol 2003;21:1961-6.
57. Galai N, Safaeian M, Vlahov D, Bolotin A, Celentano DD, Study A. Longitudinal patterns of drug injection behavior in the ALIVE Study cohort,1988-2000: description and determinants. Am J Epidemiol 2003;158:695-704.
58. Alavanja MC, Sandler DP, McDonnell CJ, et al. Characteristics of pesticide use in a pesticide applicator cohort: the Agricultural Health Study. Environ Res 1999;80:172-9.
59. Bernstein L, Allen M, Anton-Culver H, et al. High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States). Cancer Causes Control 2002;13:625-35.
60. Tsilidis KK, Erlinger TP, Rifai N, et al. C-reactive protein and colorectal adenoma in the CLUE II cohort. Cancer Causes Control 2008;19:559-67.
61. Helzlsouer KJ, Alberg AJ, Huang HY, et al. Serum concentrations of organochlorine compounds and the subsequent development of breast cancer. Cancer Epidemiol Biomarkers Prev 1999;8:525-32.
62. Splansky GL, Corey D, Yang Q, et al. The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol 2007;165:1328-35.
63. Boyer BB, Mohatt GV, Plaetke R, et al. Metabolic syndrome in Yup'ik Eskimos: the Center for Alaska Native Health Research (CANHR) Study. Obesity (Silver Spring) 2007;15:2535-40.
64. Tomeo CA, Field AE, Berkey CS, Colditz GA, Frazier AL. Weight concerns, weight control behaviors, and smoking initiation. Pediatrics 1999;104:918-24.
65. Grobbee DE, Rimm EB, Giovannucci E, Colditz G, Stampfer M, Willett W. Coffee, caffeine, and cardiovascular disease in men. N Engl J Med 1990;323:1026-32.
66. Rausch SM, Millay S, Scott C, et al. Health behaviors among cancer survivors receiving screening mammography. Am J Clin Oncol 2012;35:22-31.
67. Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, Rinaldo CR, Jr. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 1987;126:310-8.
68. Blair A, Stewart PA, Hoover RN. Mortality from lung cancer among workers employed in formaldehyde industries. Am J Ind Med 1990;17:683-99.
69. Harris KM, Perreira KM, Lee D. Obesity in the transition to adulthood: predictions across race/ethnicity, immigrant generation, and sex. Arch Pediatr Adolesc Med 2009;163:1022-8.
70. Madans JH, Cox CS, Kleinman JC, et al. 10 years after NHANES I: mortality experience at initial followup, 1982-84. Public Health Rep 1986;101:474-81.
71. Schatzkin A, Subar AF, Thompson FE, et al. Design and serendipity in establishing a large cohort with wide dietary intake distributions: the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol 2001;154:1119-25.
72. Barton J, Bain C, Hennekens CH, et al. Characteristics of respondents and non-respondents to a mailed questionnaire. Am J Public Health 1980;70:823-5.
73. Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, et al. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 1995;87:190-7.
74. Khawaja O, Sarwar A, Albert CM, Gaziano JM, Djousse L. Sleep duration and risk of atrial fibrillation (from the Physicians' Health Study). Am J Cardiol 2013;111:547-51.
75. Matise TC, Ambite JL, Buyske S, et al. The Next PAGE in understanding complex traits: design for the analysis of Population Architecture Using Genetics and Epidemiology (PAGE) Study. Am J Epidemiol 2011;174:849-59.
76. Andriole GL, Reding D, Hayes RB, Prorok PC, Gohagan JK, Committee PS. The prostate, lung, colon, and ovarian (PLCO) cancer screening trial: Status and promise. Urol Oncol 2004;22:358-61.
77. White E, Patterson RE, Kristal AR, et al. VITamins And Lifestyle cohort study: study design and characteristics of supplement users. Am J Epidemiol 2004;159:83-93.
78. Herd P, Carr D, Roan C. Cohort profile: Wisconsin longitudinal study (WLS). Int J Epidemiol 2014;43:34-41.
79. Hays J, Hunt JR, Hubbell FA, et al. The Women's Health Initiative recruitment methods and results. Ann Epidemiol 2003;13:S18-77.
80. Rexrode KM, Lee IM, Cook NR, Hennekens CH, Buring JE. Baseline characteristics of participants in the Women's Health Study. J Womens Health Gend Based Med 2000;9:19-27.
81. Barkan SE, Melnick SL, Preston-Martin S, et al. The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology 1998;9:117-25.
82. McCarty CA, Giampietro PF, Wesbrook SD, Caldwell MD. Marshfield Clinic Personalized Medicine Research Project (PMRP): design, methods and recruitment for a large poplulation-based biobank. Per Med 2005;2:49-79.
83. Bild DE, Bluemke DA, Burke GL, et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol 2002;156:871-81.
84. Satia JA, Galanko JA, Rimer BK. Methods and strategies to recruit African Americans into cancer prevention surveillance studies. Cancer Epidemiol Biomarkers Prev 2005;14:718-21.
85. Rosenberg L, Palmer JR, Rao RS, Adams-Campbell LL. Correlates of postmenopausal female hormone use among black women in the United States. Obstet Gynecol 1998;91:454-8.
86. Weinberg CR, Shore DL, Umbach DM, Sandler DP. Using risk-based sampling to enrich cohorts for endpoints, genes, and exposures. Am J Epidemiol 2007;166:447-55.